Significant weight loss in patients with schizophrenia in long-term hypocaloric diet: a pilot study
Perda significativa de peso em pacientes com esquizofrenia na dieta hipocalórica de longo prazo: estudo piloto
Karine Zortéa, Lísia Rejane Guimarães, Viviane Carvalho Franco, Clarissa Severino Gama, Paulo Silva Belmonte-de-Abreu
Abstract
Objective: Schizophrenia is associated with increased obesity and morbidity from cardiovascular disease. The aim of the present study was to evaluate changes in weight and body mass index (BMI) of patients with schizophrenia following a long-term nutritional treatment. Methods: Retrospective pilot study involving 42 individuals with schizophrenia on nutritional treatment from 2004 to 2010. Medical charts were reviewed after institutional approval and data collection was conducted for weight, body mass index (BMI), age, gender and diet prescription. Weight and BMI were evaluated at baseline of nutrition treatment, after six months, after 12 months and at the time of data collection. Results: There was a significant weight loss and significant decreased in BMI when compared each group to baseline (p<0.001). Conclusions: We demonstrate that nutritional interventions can promote a significant weight loss in schizophrenia. These results support the importance of nutritional intervention in schizophrenia and bring evidences that weight loss remains along the time.
Keywords
Resumo
Objetivo: A esquizofrenia está associada ao aumento da obesidade e morbidade por doença cardiovascular. O objetivo do presente estudo foi avaliar alterações no peso e índice de massa corporal (IMC) de pacientes com esquizofrenia após tratamento nutricional de longo prazo. Método: Estudo piloto retrospectivo envolvendo 42 indivíduos com esquizofrenia em tratamento nutricional entre 2004 e 2010. Os prontuários médicos foram revisados após aprovação institucional e coleta de dados para peso, índice de massa corporal (IMC), idade, gênero e dieta. O peso e o IMC foram avaliados no início do tratamento nutricional, após seis meses, após 12 meses e no momento da coleta de dados. Resultados: Houve perda significativa de peso e diminuição significativa do IMC quando comparados a cada grupo com o valor basal (p<0,001). Conclusões: Demonstramos que as intervenções nutricionais podem promover uma significativa perda de peso na esquizofrenia. Estes resultados suportam a importância da intervenção nutricional na esquizofrenia e trazem evidências de que a perda de peso permanece ao longo do tempo.
Palavras-chave
Referências
1. Bresee LC, Majumdar SR, Patten SB, Johnson JA. Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia. Eur Psychiatry. 2011;26(5):327-32.
2. Zortéa K, Guimarães LR, Gama CS, Belmonte-de-Abreu PS. Nutritional status of patients with schizophrenia who attend the Psychosocial Care Center (CAPS), Hospital de Clínicas de Porto Alegre. J Bras Psiquiatr. 2010;59(2):126-30.
3. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86(1-3):15-22.
4. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Metabolic syndrome in first episode schizophrenia - a randomized doubleblind controlled, short-term prospective study. Schizophr Res. 2008;101(1-3):266-72.
5. Davoodi N, Kalinichev M, Korneev SA, Clifton PG. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine. Psychopharmacology (Berl). 2009;203(4):693-702.
6. Heald A. Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry. 2010;25(Suppl 2):S6-11.
7. Jean-Baptiste M, Tek C, Liskov E, Chakunta UR, Nicholls S, Hassan AQ, et al. A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res. 2007;96(1-3):198-205.
8. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006;86(1-3):36-44.
9. Strassnig M, Singh Brar J, Ganguli R. Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res. 2005;76(2-3):343-51.
10. Chaudhry IB, Jordan J, Cousin FR, Cavallaro R, Mostaza JM. Management of physical health in patients with schizophrenia: international insights. Eur Psychiatry. 2010;25(Suppl 2):S37-40.
11. Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis. 2008;18(2):158-68.
Submetido em:
24/08/2016
Aceito em:
03/11/2016
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email